Clinical trials
Carcinoma, Squamous Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 11 |
| Recruiting | 4 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 6 |
| Merck Sharp & Dohme LLC | 3 |
| Karyopharm Therapeutics Inc | 2 |
| McMaster University | 2 |
| Pfizer | 2 |
| University of Calgary | 2 |
| Women's College Hospital | 2 |
| AHS Cancer Control Alberta | 1 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Alpha Tau Medical LTD. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 45 |
| Squamous Cell Carcinoma of Head and Neck | 14 |
| Head and Neck Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Adenocarcinoma | 5 |
| Carcinoma | 5 |
| Basal Cell Carcinoma | 4 |
| Carcinoma, Large Cell | 4 |
| Colorectal Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
Trials
Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.